Skip to main content

Botox (Botulinum Toxin) Treatment

Botulinum toxin type A injections can temporarily soften dynamic expression lines in suitable adults. Assessment considers muscle activity, brow and eyelid position, medical history, the specific product and its authorized use in Turkey, batch traceability and follow-up. Treatment has potential risks and is not appropriate for everyone.

Treatment Information

Duration

10-15 minutes

Body Location

Forehead, glabella, crow’s feet, masseter or selected facial muscles after assessment

Preparation

Do not stop prescribed medication on your own. Tell the physician about aspirin, anticoagulants, and any medicine or supplement that may affect bleeding; changes are made only with the prescribing clinician. Report active infection or illness before treatment.

Follow-up Care

Onset and duration vary by product and individual response. The physician plans the review and any repeat treatment according to examination findings and the product labeling; there is no automatic repeat schedule.

How It Is Performed

After assessing facial movement and muscle activity, the physician injects botulinum toxin into selected muscles using a fine needle. The product, total dose and follow-up plan are recorded.

Botox vs Dermal Filler: Which One Is Right for You?

Botulinum toxin and dermal filler are often discussed together, but they address different tissues and goals. Botulinum toxin can temporarily reduce activity in selected muscles; filler may add volume or structural support in an appropriate patient. This comparison explains general decision factors; an individual choice requires facial assessment, medical history, and examination.

Botox vs Dermal Filler: Which One Is Right for You?
CriterionBotox (Botulinum Toxin)Dermal Filler (Hyaluronic Acid)
Primary GoalRelaxes expression muscles to reduce dynamic wrinkles (forehead, glabellar lines, crow's feet).Restores volume loss, fills static lines and contours (lips, cheeks, nasolabial folds).
Mechanism of ActionBlocks acetylcholine release to temporarily reduce muscle contraction.Delivers hyaluronic acid to tissue; binds water between cells, adds volume and structural support.
Procedure Duration10–15 minutes30–45 minutes
Onset of Results3–7 days, full effect at 2 weeksImmediately visible; settles over 1–2 weeks as swelling resolves
Longevity3–4 months9–18 months depending on product
Reversible?Its effect fades over time; there is no standard method that immediately reverses treatment.Some hyaluronic-acid fillers may be reduced with physician-directed hyaluronidase; the speed and extent of response vary. Suspected vascular occlusion requires urgent assessment.
DowntimeReturn to routine is often quick; bruising, headache, or temporary asymmetry can occur.Swelling and bruising can occur; duration varies by area, product, and individual response.
Findings That Guide the ChoiceLines driven by muscle movement, muscle strength, and the balance of adjacent structures.Volume loss, contour needs, tissue quality, and vascular anatomy.
How Is the Fee Determined?The muscles assessed, dose, product, and review plan are determined after physician examination.Product type, amount, treatment area, technique, and follow-up plan are determined after physician examination.

Dr. Gemici's Recommendation

Movement-related lines may prompt a botulinum-toxin assessment, while volume or structural-support needs may prompt a filler assessment. Some people may be considered for both approaches at different times, but age alone is not a decision rule. Suitability, expected benefit, and risks should be discussed during an in-person physician assessment.

Botulinum toxin decision guide

Botulinum toxin: suitability, product verification and follow-up

A responsible plan starts with the clinical goal, examination and the exact product. A brand name, a standard number of units or a recurring booking is not an individual treatment plan.

Who may be suitable?

Dynamic facial lines may be assessed after reviewing facial movement, brow and eyelid position, medical history, medicines and previous treatments. Some concerns need another approach or no procedure.

What should be checked about the product?

Ask about the exact medicine, manufacturer, batch, expiry date, source, storage and authorized indication in Turkey. A US approval does not establish Turkish authorization. Units are product-specific and cannot be directly converted between brands.

What makes the plan individual?

Anatomy, muscle activity, prior response and the chosen product inform planning. A comparison study using equal numerical doses does not prove universal dose equivalence. This guide does not provide self-injection or dosing instructions.

Does follow-up mean another injection?

No. Review assesses response and unwanted effects. Additional or repeat treatment depends on examination, the product information and the individual situation; it is not an automatic fixed schedule.

Which symptoms need urgent attention?

Difficulty breathing, swallowing or speaking, or generalized weakness after treatment needs urgent medical assessment. Do not wait for a routine follow-up. Bruising and local discomfort are different from these warning signs.

Frequently Asked Questions

Safety and complication management

Botox (Botulinum Toxin) Treatment is a safe procedure; still, as with any medical treatment, explaining possible side effects and rare complications transparently is part of patient safety. The physician-authored guides below cover these topics in depth.

This content is informational and does not replace medical advice. At any warning sign, contact the physician who performed the procedure or the nearest medical facility without delay.

Botox (Botulinum Toxin) Treatment — Related Medical Terms

Deep-dive in our glossary: definition, indications, side effects and FAQs.

Baby Botox

Baby Botox is an intramuscular injection treatment that aims to prevent wrinkles in young patients between the ages of 20-35, with a dose reduced to 30-50% of the classical botox, and gives maximum priority to preserving natural facial expressions.

Axillary Hyperhidrosis (Excessive Armpit Sweating)

Axillary hyperhidrosis, primary focal hyperhidrosis coded with ICD-10 R61.0, which causes excessive sweat secretion throughout the day, regardless of stress, due to the hyperactive operation of the eccrine sweat glands in the armpit area due to sympathetic cholinergic innervation; HDSS ≥ 3 is a medical condition that significantly reduces the quality of life of patients and provides 75-90% sweat reduction with Botox gold standard treatment.

Dysport (Abobotulinumtoxin-A)

Dysport is a muscle-nerve blocking injection treatment containing the active ingredient Botulinum toxin type A (abobotulinumtoxin-A) produced by Ipsen, approved by FDA (2009) and TITCK, which reduces dynamic wrinkles by blocking facial expression muscles; It is known as a Botox alternative.

Daxxify (Daxibotulinumtoxin-A)

Daxxify; Botulinum toxin type A product, developed by Revance Therapeutics, containing a peptide stimulator (RTP-004) and approved by the FDA for cosmetic indication in 2022, used in the treatment of glabellar wrinkles; It is a longer-acting alternative to Botox, with an effect duration of up to 6 months.

Jeuveau (PrabotulinumtoxinA-xvfs)

Jeuveau is a prescription botulinum toxin injection authorized in the US for specified adult glabellar lines; its units are not interchangeable with those of other toxin products.

Sources & Regulatory Authorities

These are selected peer-reviewed medical publications. Findings are limited to the studied product, device and indication; authorization and administration route require separate verification. Publication titles are retained in their original language for reliable lookup.

A double-blind, placebo-controlled trial in 264 participants supports the studied botulinum toxin A product for glabellar lines. Results do not automatically apply to every brand, dose or facial area.

Evidence summary reviewed by Dr. Hamza Gemici · · Review log

Scientific References (PubMed / Cochrane)

  1. Carruthers JA, Lowe NJ, Menter MA et al.. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. · J Am Acad Dermatol (2002)

    PMID 12063480DOI 10.1067/mjd.2002.121356

Related Services

Plan an Assessment

Contact Dr. Hamza Gemici’s clinic for individualized assessment and candidacy planning.